Medical News

RSS

Stress and alcohol can trigger domestic violence during holiday season

The holidays are supposed to be a time for family togetherness and cheer, yet for many women and children, they are instead a time of fear and violence.

16 Dec 2009

Idaho Technology signs licensing agreement with Kapa Biosystems

Idaho Technology, Inc. has signed a licensing agreement with Kapa Biosystems, Inc., covering reagents or methods using SYBR® Green I technology and melting curve analysis for real time PCR.

16 Dec 2009

Majority of workers believe swine flu may impact workflow and productivity

Adecco Group North America's latest American Workplace Insights Survey finds that 77% of workers(1) think their workplace will be impacted in some way by the swine flu.

16 Dec 2009

TRAPPC9 as gene may be associated with intellectual disability world-wide, scientists identify

A gene involved in some forms of intellectual disability has been identified by scientists at the Centre for Addiction and Mental Health (CAMH), as published this month in The American Journal of Human Genetics. The gene is called TRAPPC9.

16 Dec 2009

Carrier screening reduces CF birth rates in northeast Italy

An increase in the number of screened carriers for cystic fibrosis (CF) was associated with a decrease in the number of children born with CF in northeast Italy, according to a study in the December 16 issue of JAMA.

16 Dec 2009

Results from five new studies on Genomic Health's Oncotype DX breast cancer test announced

Genomic Health, Inc. today announced results from five new studies on its Oncotype DX® breast cancer test, a multi-gene expression test that physicians currently use to predict the likelihood of chemotherapy benefit and recurrence risk for patients with early-stage breast cancer.

16 Dec 2009

FDA grants approval to market InterSol platelet additive solution

Fenwal Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that the U.S. Food and Drug Administration has granted Fenwal approval to market InterSol® platelet additive solution.

15 Dec 2009

Participating in social service programs can delay cognitive decline in older adults

Volunteer service, such as tutoring children, can help older adults delay or reverse declining brain function, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health.

15 Dec 2009

Dendritic cell changes suggest new strategy to identify and treat debilitating lung disease

A new study links chronic obstructive pulmonary disease, or COPD, with increased activity of cells that act as sentinels to activate the body's immune system.

15 Dec 2009

DSMB approves advancement of PLX-PAD to intermediate dose level in Phase I clinical trial for CLI treatment

Pluristem Therapeutics Inc. today announced that the independent DSMB approved the advancement to the intermediate dose level of the company’s placenta derived cell therapy, PLX-PAD, in the Phase I clinical trial in Europe for the treatment of critical limb ischemia (CLI), the end stage of peripheral artery disease (PAD).

15 Dec 2009

Vangent to implement SSO and Context Management capability in Military Health System

Vangent, Inc., a leading global provider of information management and strategic business process solutions, announced today it was awarded a $20 million contract by the Department of Defense (DoD) to implement an integrated Single Sign-On (SSO) and Context Management capability throughout the Military Health System.

15 Dec 2009

Hospira to acquire Orchid's pharmaceuticals business for $400 million

Hospira, Inc., the world leader in generic injectable pharmaceuticals, and Orchid Chemicals & Pharmaceuticals Ltd., a leading Indian pharmaceuticals company and among the top-five generic beta-lactam antibiotics manufacturers globally, today announced an agreement for Hospira to acquire Orchid's generic injectable finished-dosage form pharmaceuticals business for approximately $400 million.

15 Dec 2009

BioAlliance Pharma SA to enter Phase II clinical trial for clonidine Lauriad and Phase I clinical trial for AMEP

BioAlliance Pharma SA, a company dedicated to the treatment and supportive care of cancer and AIDS patients, today announces the approval from the French Drug Agency (AFFSSaPS) to enter Phase II clinical trial for clonidine Lauriad® in radiotherapy and chemotherapy-induced oral mucositis and the approval from Danish and Slovene Agencies to enter Phase I clinical trial for AMEPTM in invasive melanoma.

15 Dec 2009

Flextronics acquires SloMedical S.R.O

Flextronics today announced that it has completed the previously announced acquisition of SloMedical S.R.O., a leading European manufacturer of disposable medical devices ranging from tubing sets to complex devices for minimally-invasive surgery.

15 Dec 2009

FDA opens third city post in Latin America

As part of its continuing effort to buttress food and medical product safety in this country by working with its regulatory partners overseas, the U.S. Food and Drug Administration today announced the opening of its Mexico City post. This is the Agency's third post in Latin America and its tenth international post in the past 13 months.

15 Dec 2009

Advaxis to collaborate with GOG in Phase II clinical trial of ADXS11-001

Advaxis, Inc., the live, attenuated Listeria monocytogenes (Lm) vaccine company, will collaborate with the Gynecologic Oncology Group (GOG), a collaborative research group of the National Cancer Institute (NCI), in a multicenter, Phase II clinical trial of the Company’s lead drug candidate, ADXS11-001 in the treatment of advanced cervix cancer in women who have failed prior cytotoxic therapy.

15 Dec 2009

CHUM neurosurgeon raises funds for epilepsy research

On January 8, 2010, CHUM neurosurgeon Dr. Alain Bouthillier will leave for Argentina, where he will brave the 6,962-metre heights (over 22,840 feet) of Mount Aconcagua. Dr. Bouthillier's climb is intended to raise public awareness about epilepsy and raise funds for further research on the illness.

15 Dec 2009

Tarenflurbil drug does not appear to benefit Alzheimer’s patients

Although there were promising results in a phase 2 trial, patients with mild Alzheimer disease who received the drug tarenflurbil as part of a phase 3 trial did not have better outcomes on measures of cognitive decline or loss of activities of daily living compared to patients who received placebo, according to a study in the December 16 issue of JAMA.

15 Dec 2009

Tips to prevent noise-induced hearing loss in children

Parents and children giving or receiving an electronic device with music this holiday season should give their ears a gift as well by pre-setting the maximum decibel level to somewhere between one-half and two-thirds maximum volume.

15 Dec 2009

Lilly Endowment offers $60 million to implement the Indiana Physician Scientist Initiative

When a patient has a disease that can't be treated effectively, the physician can see clearly where research is needed.

15 Dec 2009

Medical News

Stress and alcohol can trigger domestic violence during holiday season

Idaho Technology signs licensing agreement with Kapa Biosystems

Majority of workers believe swine flu may impact workflow and productivity

TRAPPC9 as gene may be associated with intellectual disability world-wide, scientists identify

Carrier screening reduces CF birth rates in northeast Italy

Results from five new studies on Genomic Health's Oncotype DX breast cancer test announced

FDA grants approval to market InterSol platelet additive solution

Participating in social service programs can delay cognitive decline in older adults

Dendritic cell changes suggest new strategy to identify and treat debilitating lung disease

DSMB approves advancement of PLX-PAD to intermediate dose level in Phase I clinical trial for CLI treatment

Vangent to implement SSO and Context Management capability in Military Health System

Hospira to acquire Orchid's pharmaceuticals business for $400 million

BioAlliance Pharma SA to enter Phase II clinical trial for clonidine Lauriad and Phase I clinical trial for AMEP

Flextronics acquires SloMedical S.R.O

FDA opens third city post in Latin America

Advaxis to collaborate with GOG in Phase II clinical trial of ADXS11-001

CHUM neurosurgeon raises funds for epilepsy research

Tarenflurbil drug does not appear to benefit Alzheimer’s patients

Tips to prevent noise-induced hearing loss in children

Lilly Endowment offers $60 million to implement the Indiana Physician Scientist Initiative

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News